El mercado de vacunas contra la fiebre tifoidea fue valorado en 262,81 millones de dólares en 2019 y se prevé que alcance los 525,32 millones de dólares en 2027; se espera que crezca a una tasa compuesta anual del 9,3 % entre 2020 y 2027.
La fiebre tifoidea es una enfermedad infecciosa causada por alimentos y agua contaminados. La tifoidea es una infección bacteriana que puede provocar fiebre alta y es causada por la bacteria Salmonella typhi. Esta enfermedad es rara en los países desarrollados y se recomiendan vacunas en las zonas donde prevalece la enfermedad. Existen dos tipos de vacunas para prevenir la fiebre tifoidea. Una es una vacuna inactivada (muerta) y la otra es una vacuna viva atenuada (debilitada) contra la fiebre tifoidea. La vacuna tifoidea inactivada se administra mediante inyección.
El alcance del mercado de Vacunas contra la fiebre tifoidea incluye el procedimiento, el tipo de vacunas contra la fiebre tifoidea, la vía de administración y la región. El mercado de las vacunas contra la fiebre tifoidea se analiza en función de regiones como América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y América del Sur y Central. El informe ofrece información y un análisis en profundidad del mercado de vacunas contra la fiebre tifoidea haciendo hincapié en varios parámetros, como las tendencias del mercado, los avances tecnológicos, la dinámica del mercado y el análisis del panorama competitivo de los principales actores del mercado en todo el mundo.
  ;
Perspectivas estratégicas
regiones lucrativas para el mercado de vacunas contra la fiebre tifoidea
Perspectivas del mercado
Número creciente de pacientes que padecen tifoidea
La fiebre tifoidea se refiere a una infección sistémica causada por Salmonella Typhi que generalmente se ingiere a través de agua o alimentos contaminados. La enfermedad infecciosa suele deberse principalmente a la falta de agua potable y a una mala higiene. Se sabe que la fiebre tifoidea es la fiebre más común en las economías rurales y subdesarrolladas. Según estimaciones recientes de la Organización Mundial de la Salud (OMS), la fiebre tifoidea es una fiebre endémica en África, Asia, América Latina, Oceanía y el Caribe. La OMS también afirma que el 80% de los casos de fiebre tifoidea surgen en India, Bangladesh, China, Laos, Nepal, Indonesia, Vietnam y Pakistán. Según un estudio reciente del All India Institute of Medical Sciences (AIIMS), alrededor de 494 de cada 100.000 niños de entre 5 y 15 años sufrieron tifoidea en 2017.
Según el Según los Centros para el Control y la Prevención de Enfermedades (CDC), la mayoría de los casos de fiebre tifoidea en los EE. UU. surgen entre viajeros internacionales. Según un estudio publicado en Lancet: Infectious Diseases, la fiebre tifoidea infecta a ~21,6 millones de personas en todo el mundo y es responsable de la muerte de unas 200.000 personas cada año. Además, la inestabilidad económica en América Latina y algunas de las otras economías subdesarrolladas ha llevado a un saneamiento inadecuado y un acceso limitado a agua potable y alimentos, lo que está generando un alto riesgo de incidencia de tifoidea. Según los Servicios Nacionales de Salud (NHS), los niños experimentan el mayor riesgo de infección tifoidea en todo el mundo debido al creciente grado de inmunidad entre los niños.
Por lo tanto, la creciente incidencia de fiebre tifoidea y Es probable que el alto riesgo de transmisión a través de alimentos y agua contaminados impulse la demanda de vacunas contra la fiebre tifoidea, apoyando así el crecimiento del mercado en los próximos años.
Vacunas contra la fiebre tifoidea Tipo- BasedInsights
Mercado global de vacunas contra la fiebre tifoidea, según el tipo de vacunas contra la fiebre tifoidea, el mercado de vacunas contra la fiebre tifoidea se segmenta en vacunas vivas atenuadas, vacunas de polisacáridos capsulares, vacuna conjugada y otras. En 2019, el segmento de vacunas de polisacáridos capsulares representó la mayor participación del mercado. El crecimiento de este segmento se atribuye a la eficacia asociada a la prevención de infecciones y al aumento del grupo de pacientes en todo el mundo. Es probable que el segmento de vacunas vivas atenuadas registre la CAGR más alta en el mercado mundial de vacunas contra la fiebre tifoidea durante el período de pronóstico.
&n bsp; &n bsp; &n bsp;
Mercado mundial de vacunas contra la fiebre tifoidea, por Vacunas contra la fiebre tifoidea Tipo: 2019 y 2019 2027Información basada en la vía de administración
Mercado global de vacunas contra la fiebre tifoidea, según la vía de administración, El mercado de vacunas contra la fiebre tifoidea se segmenta en orales e inyecciones. El segmento inyectable tuvo la mayor participación del mercado en 2019, mientras que se prevé que el segmento oral registre la CAGR más alta del 10,1% en el mercado durante el período previsto.
La pandemia de COVID-19 se ha convertido en el desafío más importante en todo el mundo. Este desafío será aterrador, especialmente en los países en desarrollo de todo el mundo, ya que conducirá a una reducción de las importaciones debido a las perturbaciones en el comercio mundial, lo que aumenta aún más la escasez de suministros médicos y otros bienes, lo que resultará en un aumento considerable de los precios. La Organización Mundial de la Salud y UNICEF advirtieron sobre una disminución alarmante en el número de niños que reciben vacunas que salvan vidas en todo el mundo. Esto se debe a las interrupciones en la prestación y aceptación de los servicios de inmunización provocadas por la pandemia de COVID-19. En 2019, UNICEF adquirió aproximadamente 2430 millones de dosis de vacunas en alrededor de 100 países para llegar a alrededor del 45 % de los niños del mundo menores de 5 años.
Las empresas suelen adoptar lanzamientos de productos y estrategias de expansión para expandir su presencia en todo el mundo y satisfacer la creciente demanda. Estas estrategias son comúnmente adoptadas por los actores del mercado para ampliar su cartera de productos.
Los actores del mercado que operan en el mercado de vacunas contra la fiebre tifoidea adoptaron la estrategia de innovación de productos para atender a la cambiante demanda de los clientes en todo el mundo, lo que también permite a los jugadores mantener su marca a nivel mundial.
Por tipo
- Vivo atenuado Vacuna
- Vacunas de polisacáridos capsulares
- Vacuna conjugada
- Otras
Por vía de Administración   ;
- Inyecciones orales
- Inyecciones
Por geografía
- América del Norte
- Estados Unidos
- Canadá
- México
- Europa
- Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico(APAC)
- China
- India
- Corea del Sur
- Japón
- Australia< /li>
- Resto de Asia Pacífico
- Medio Oriente y Asia África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de Medio Oriente y África
- América del Sur (SAM)
- Brasil
- Argentina
- Resto de América del Sur
Perfiles de empresas
- Instituto de productos biológicos co., ltd. de Shanghai
- Paxvax Inc.
- PT Bio Farma
- BIO-MED
- BHARAT BIOTECH
- Sanofi
- GlaxoSmithKline plc. < li>Prokarium Ltd.
- BIOPHARMA ESCANDINAVA
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Typhoid is an infectious diseases caused due to contaminated food and water. Typhoid is a bacterial infection that can lead to a high fever and it is caused by the bacteria Salmonella typhi. This disease is rare in developed countries and vaccines are recommended in the areas where the disease is prevalent. There are two types of vaccines to prevent typhoid fever. One is an inactivated (killed) vaccine and the other is a live, attenuated (weakened) typhoid fever vaccine. Inactivated typhoid vaccine is administered as an injection.
The factors that are driving growth of the market are Growing Number of Patients Suffering with Typhoid and Organizations Supporting Typhoid Immunizations are expected to boost the growth of the global Typhoid fever vaccines market.
The Typhoid fever vaccinesmarket majorly consists of the players such as Shanghai institute of biological products co., ltd., Paxvax Inc.,PT Bio Farma, BIO-MED, BHARAT BIOTECH, Sanofi, GlaxoSmithKline plc., Prokarium Ltd., Scandinavian Biopharmaand among others.
The List of Companies - Typhoid Fever Vaccines Market
- Shanghai institute of biological products co., ltd.
- BHARAT BIOTECH
- Sanofi
- GlaxoSmithKline plc.
- Paxvax Inc.
- PT Bio Farma
- BIO-MED
- Prokarium Ltd.
- Scandinavian Biopharma
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Oct 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Oct 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Oct 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)